Abstract
Semantic memory decline has been found in Mild Cognitive Impairment (MCI). In this study performance on a range of semantic tasks and structural brain patterns were examined in a group of MCI patients. Fourteen MCI and sixteen healthy elderly controls underwent semantic memory assessment and MRI brain scanning. The cognitive battery included visual naming and naming from definition tasks for objects, actions and famous people, semantic fluency for animals, fruits, tools, furniture, singers, politicians, actions, word-association task for early and late acquired words and a reading task. MCI patients performed worse on semantic fluency in all categories except for tools, produced a smaller number of words associated with early acquired nouns and a smaller total number of word-associations. Patients scored more poorly in all tasks of naming, naming of famous people, overall reading and reading of famous people’s names. MCIs had fewer correct immediate recalls and more correct responses with cue in famous people naming, made more errors in naming and in the naming from definition task for famous people. Grey matter reduction in parahippocampus, frontal and cingulate cortices and amygdala was found in the MCI sample when compared with controls. Patients presented a different pattern of brain areas correlated with semantic tasks from that seen in controls, with more extensive involvement of subcortical regions in semantic fluency and word-association and more contribution of frontal than temporo-parietal areas in visual naming. This evidence suggests a reorganization of cortical associations of semantic processes in MCI that, following damage in the semantic circuit, explains its progressive breakdown.
Keywords: Semantic memory, cognitive decline, mild cognitive impairment, dementia, Alzheimer's disease, MRI
Current Alzheimer Research
Title:Brain Structural Substrates of Semantic Memory Decline in Mild Cognitive Impairment
Volume: 10 Issue: 4
Author(s): Simona Gardini, Fernando Cuetos, Fabrizio Fasano, Francesca Ferrari Pellegrini, Massimo Marchi, Annalena Venneri and Paolo Caffarra
Affiliation:
Keywords: Semantic memory, cognitive decline, mild cognitive impairment, dementia, Alzheimer's disease, MRI
Abstract: Semantic memory decline has been found in Mild Cognitive Impairment (MCI). In this study performance on a range of semantic tasks and structural brain patterns were examined in a group of MCI patients. Fourteen MCI and sixteen healthy elderly controls underwent semantic memory assessment and MRI brain scanning. The cognitive battery included visual naming and naming from definition tasks for objects, actions and famous people, semantic fluency for animals, fruits, tools, furniture, singers, politicians, actions, word-association task for early and late acquired words and a reading task. MCI patients performed worse on semantic fluency in all categories except for tools, produced a smaller number of words associated with early acquired nouns and a smaller total number of word-associations. Patients scored more poorly in all tasks of naming, naming of famous people, overall reading and reading of famous people’s names. MCIs had fewer correct immediate recalls and more correct responses with cue in famous people naming, made more errors in naming and in the naming from definition task for famous people. Grey matter reduction in parahippocampus, frontal and cingulate cortices and amygdala was found in the MCI sample when compared with controls. Patients presented a different pattern of brain areas correlated with semantic tasks from that seen in controls, with more extensive involvement of subcortical regions in semantic fluency and word-association and more contribution of frontal than temporo-parietal areas in visual naming. This evidence suggests a reorganization of cortical associations of semantic processes in MCI that, following damage in the semantic circuit, explains its progressive breakdown.
Export Options
About this article
Cite this article as:
Gardini Simona, Cuetos Fernando, Fasano Fabrizio, Ferrari Pellegrini Francesca, Marchi Massimo, Venneri Annalena and Caffarra Paolo, Brain Structural Substrates of Semantic Memory Decline in Mild Cognitive Impairment, Current Alzheimer Research 2013; 10 (4) . https://dx.doi.org/10.2174/1567205011310040004
DOI https://dx.doi.org/10.2174/1567205011310040004 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
Early nutritional intervention and physical activity in the prevention of Alzheimer's disease and other dementias
The aim is to broaden the knowledge about the impact of the consumption of food ingredients, diet ingredients, methods of processing of food raw materials as well as the impact of composing of diets on the possibility of preventing Alzheimer's disease and other types of dementia at each stage of ...read more
Enhancing Alzheimer's Disease Diagnosis and Treatment Efficacy Prediction with Explainable AI, Radiomics, Biomarkers, and Multimodal Neuroimaging
The thematic issue, Enhancing Alzheimer's Disease Diagnosis and Treatment Efficacy Prediction with Explainable AI, Radiomics, Biomarkers, and Multimodal Neuroimaging, aims to bridge the gap between advanced computational techniques and clinical practice in Alzheimer’s disease research. Alzheimer’s disease poses significant challenges in early diagnosis, disease progression monitoring, and predicting treatment efficacy. ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel AβIsoforms in Alzheimer's Disease - Their Role in Diagnosis and Treatment
Current Pharmaceutical Design Editorial [Hot topic: Fixing Alzheimer Disease Trials by Improving Process and Methods (Lon S. Schneider)]
Current Alzheimer Research Frailty of Older Age: The Role of the Endocrine - Immune Interaction
Current Pharmaceutical Design Mean Platelet Volume: A Link Between Thrombosis and Inflammation?
Current Pharmaceutical Design Approaches to a Multitargeting Drug Development: First Profiled 3- Ethoxycarbonyl-1-aza-9-oxafluorenes Representing a Perspective Compound Class Targeting Alzheimer Disease Relevant Kinases CDK1, CDK5 and GSK-3β
Medicinal Chemistry The Journey From Metabolic Profiling to Biomarkers: The Potential of NMR Spectroscopy Based Metabolomics in Neurodegenerative Disease Research
Current Metabolomics Herbal Medicine for Anxiety, Depression and Insomnia
Current Neuropharmacology Sigma-1 Receptor Agonists as Therapeutic Drugs for Cognitive Impairment in Neuropsychiatric Diseases
Current Pharmaceutical Design Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinsons Disease
Current Neuropharmacology A New Decision Tree Combining Abeta 1-42 and p-Tau Levels in Alzheimer's Diagnosis
Current Alzheimer Research Body Mass Index in Midlife and Risk of Alzheimer Disease and Vascular Dementia
Current Alzheimer Research Vitamin E and All-Cause Mortality: A Meta-Analysis
Current Aging Science Mitochondrial Proteases as Emerging Pharmacological Targets
Current Pharmaceutical Design Inflammation, Endothelial Dysfunction and Arterial Stiffness as Therapeutic Targets in Cardiovascular Medicine
Current Pharmaceutical Design Effects of ε4 on Object Recognition in the Non-Demented Elderly
Current Aging Science Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, α -Synuclein Synthesis, Interleukin-1β Release, and Cholinergic Action.
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Transport Mechanisms at the Blood-Cerebrospinal-Fluid Barrier: Role of Megalin (LRP2)
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Dithiocarbamate complexes as radiopharmaceuticals for medical imaging
Mini-Reviews in Medicinal Chemistry Subclinical Hypothyroidism and Cognitive Dysfunction in the Elderly
Endocrine, Metabolic & Immune Disorders - Drug Targets Association of Dietary Prebiotic Consumption with Reduced Risk of Alzheimer’s Disease in a Multiethnic Population
Current Alzheimer Research